Source: NEWSWIRE TODAY

Press Release: Mirada Medical : BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology

NewswireToday (newswire) - BTG plc and Mirada Medical Ltd announced an important collaboration to develop dosimetry software solutions to optimise radioembolisation therapy with TheraSphere� - Mirada-Medical.com / BTGplc.com

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jon DeVries's photo - CEO of Mirada

CEO

Jon DeVries

CEO Approval Rating

82/100

Read more